Log In
BCIQ
Print this Print this
 

BBT-015

  Manage Alerts
Collapse Summary General Information
Company Bolder BioTechnology Inc.
DescriptionLong-acting granulocyte colony-stimulating factor (G-CSF) analog
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationNeutropenia
Indication DetailsTreat neutropenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today